Design and study of peptide-based inhibitors of amylin cytotoxicity |
| |
Authors: | Karen Muthusamy Per I. Arvidsson Patrick Govender Hendrik G. Kruger Glenn E.M. Maguire Thavendran Govender |
| |
Affiliation: | 1. School of Pharmacy and Pharmacology, University of KwaZulu Natal, South Africa;2. Department of Biochemistry, University of KwaZulu Natal, South Africa;3. Department of Biochemistry & Organic Chemistry, Uppsala University, Sweden;4. Medicinal Chemistry, Discovery CNS & Pain Control, AstraZeneca R&D Södertälje, S-151 85 Södertälje, Sweden;5. School of Chemistry, University of KwaZulu Natal, South Africa |
| |
Abstract: | The incidence of type II diabetes is on the increase each year and the World Health Organisation (WHO) predicts there to be over 360 million diabetic patients worldwide by the year 2030. Deposits consisting mainly of a small protein, called islet amyloid polypeptide (amylin), which aggregates into oligo-/polymeric beta sheet structures is responsible for cytoxicity to the pancreatic β-cells, thus inhibition of this process has been explored as a potential prevention or treatment. N-Methylated and non N-methylated peptides spanning the length of amylin1–37 were synthesised and evaluated for their inhibition of full length amylin mediated cytoxicity to RIN-5F cells. The non N-methylated peptides were very effective in inhibiting the cytotoxicity while the N-methylated peptides were not. Both the N-methylated and non N-methylated versions of the 29-34 region were equally effective. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|